Clinical trials recruiting for Resectable Pancreatic Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Nab-paclitaxel | 2 |
| Gemcitabine | 1 |
| Gemcitabine 1000 mg | 1 |
| Stereotactic Body Radiation Therapy | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Ohio | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
- Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer
- Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy
- Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
Related conditions
Trials recruiting for Resectable Pancreatic Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Resectable Pancreatic Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.